Dejene Tolossa Debela
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 1
- Toxicology top 10%
-
- Tuberculosis Research and Epidemiology 2
- HIV/AIDS Research and Interventions 1
-
- Mycobacterium research and diagnosis 2
-
- Infectious Diseases and Tuberculosis 1
-
- Meta-analysis and systematic reviews 1
-
- HIV Research and Treatment 1
-
- Global Maternal and Child Health 1
Dejene Tolossa Debela
5 papers receiving 947 citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Biomaterials 137
- Toxicology 32
- Oncology 198
- Cancer Research 99
- Molecular Medicine 31
Countries citing papers authored by Dejene Tolossa Debela
This map shows the geographic impact of Dejene Tolossa Debela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dejene Tolossa Debela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dejene Tolossa Debela more than expected).
Fields of papers citing papers by Dejene Tolossa Debela
This network shows the impact of papers produced by Dejene Tolossa Debela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dejene Tolossa Debela. The network helps show where Dejene Tolossa Debela may publish in the future.
Co-authorship network
The 6 scholars most cited alongside Dejene Tolossa Debela, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 2 | |
| 5 | New approaches and procedures for cancer treatment: Current perspectivesbreakdown → | 2021 | 946 |
| 6 | 2021 | 3 |
About Dejene Tolossa Debela
Dejene Tolossa Debela is a scholar working on Internal Medicine, Infectious Diseases and Virology, having authored 6 papers that have together received 963 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (2 papers), Mycobacterium research and diagnosis (2 papers), Nanoparticle-Based Drug Delivery (1 paper), Infectious Diseases and Tuberculosis (1 paper), Meta-analysis and systematic reviews (1 paper), HIV/AIDS Research and Interventions (1 paper), HIV Research and Treatment (1 paper) and Global Maternal and Child Health (1 paper). The work is most often cited by research in Biomaterials (137 citations), Toxicology (32 citations) and Oncology (198 citations). Dejene Tolossa Debela has collaborated with scholars based in Ethiopia, Tanzania and Zambia. Frequent co-authors include Tsegahun Manyazewal, Dawit Getachew Assefa, Ahmed Bedru, Wondwosen Molla, Nebiyu Mengistu and Michele Joseph. Their work appears in journals such as Archives of Public Health, BMC Infectious Diseases, SAGE Open Medicine, SHILAP Revista de lepidopterología and International Medical Case Reports Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.